Ibuprofen extended-release tablets

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects. It is a sustained-release dosage form that allows the drug to be gradually released in the body. Each dose can provide continuous pain relief for 12 hours.

The main ingredient of this product is: Ibuprofen. Its chemical name is: 2-(4-isobutylphenyl) propionic acid.

This product is a film-coated tablet, which appears white or off-white after removing the film coating.

Used to relieve moderate pain such as joint pain, neuralgia, muscle pain, migraine, headache, dysmenorrhea, and toothache; can also be used for fever caused by colds and flu.

Oral administration: Adults, 1 tablet at a time, 2 times a day (morning and evening).

1. A small number of patients may experience nausea, vomiting, stomach burning or mild indigestion, gastrointestinal ulcers and bleeding, increased transaminase, headache, dizziness, tinnitus, blurred vision, mental tension, drowsiness, lower limb edema or sudden weight gain; 2. Rarely, skin rash, allergic nephritis, cystitis, nephrotic syndrome, renal papillary necrosis or renal failure, and bronchospasm.

1. It is contraindicated for those who are allergic to other non-steroidal anti-inflammatory drugs; 2. It is contraindicated for pregnant and lactating women; 3. It is contraindicated for asthma patients who are allergic to aspirin.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

1. When this product is used together with other antipyretic, analgesic and anti-inflammatory drugs, it may increase gastrointestinal adverse reactions and may cause ulcers; 2. When this product is used together with anticoagulants such as heparin and dicoumarol, it may lead to prolonged prothrombin time and increased bleeding tendency; 3. When this product is used together with digoxin, methotrexate and oral hypoglycemic drugs, the blood concentration of these drugs can be increased and they should not be used together; 4. When this product is used together with furosemide (furanosemid), the latter's sodium excretion and antihypertensive effects are weakened; when used together with antihypertensive drugs, the latter's antihypertensive effect is also reduced; 5. If used together with other drugs, drug interactions may occur. Please consult your doctor or pharmacist for details.

Protect from light, store in a sealed container at room temperature.

0.3 g

24 months

APT Pharma (China) Co., Ltd.

• Founded in:

  1995-10-13

• Address:

  No. 12, Yanjiang East 2nd Road, Torch Development Zone, Zhongshan, Guangdong

• Tax NO.:

  91442000618131440B

• Registered Funds:

  HK$108.6 million

• Email:

  Log in to view